Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 121 to 125 of 125 entries
Sorted by: Best Match Show Resources per page
The effect of purging on sexually selected traits through antagonistic pleiotropy with survival.

Ecology and evolution

Bolstad GH, Pélabon C, Larsen LK, Fleming IA, Viken A, Rosenqvist G.
PMID: 22833793
Ecol Evol. 2012 Jun;2(6):1181-94. doi: 10.1002/ece3.246.

Sexually selected traits are expected to evolve to a point where their positive effect on reproductive success is counterbalanced by their negative effect on survival. At the genetic level, such a trade-off implies antagonistic pleiotropy between survival and the...

Cite
Bolstad GH, Pélabon C, Larsen LK, et al. The effect of purging on sexually selected traits through antagonistic pleiotropy with survival. Ecol Evol. 2012;2(6):1181-94doi: 10.1002/ece3.246.
Bolstad, G. H., Pélabon, C., Larsen, L. K., Fleming, I. A., Viken, A., & Rosenqvist, G. (2012). The effect of purging on sexually selected traits through antagonistic pleiotropy with survival. Ecology and evolution, 2(6), 1181-94. https://doi.org/10.1002/ece3.246
Bolstad, Geir H, et al. "The effect of purging on sexually selected traits through antagonistic pleiotropy with survival." Ecology and evolution vol. 2,6 (2012): 1181-94. doi: https://doi.org/10.1002/ece3.246
Bolstad GH, Pélabon C, Larsen LK, Fleming IA, Viken A, Rosenqvist G. The effect of purging on sexually selected traits through antagonistic pleiotropy with survival. Ecol Evol. 2012 Jun;2(6):1181-94. doi: 10.1002/ece3.246. PMID: 22833793; PMCID: PMC3402193.
Copy Download .nbib Format: NLM
Incidence of Head Contacts, Penalties, and Player Contact Behaviors in Youth Ice Hockey: Evaluating the "Zero Tolerance for Head Contact" Policy Change.

Orthopaedic journal of sports medicine

Williamson RA, Kolstad AT, Krolikowski M, Nadeau L, Goulet C, Hagel BE, Emery CA.
PMID: 33748310
Orthop J Sports Med. 2021 Mar 05;9(3):2325967121992375. doi: 10.1177/2325967121992375. eCollection 2021 Mar.

BACKGROUND: To reduce the risk of concussion in youth ice hockey, Hockey Canada implemented a national "zero tolerance for head contact" (HC) policy in 2011. A previous cohort study revealed higher concussion rates after this implementation in players aged...

Cite
Williamson RA, Kolstad AT, Krolikowski M, et al. Incidence of Head Contacts, Penalties, and Player Contact Behaviors in Youth Ice Hockey: Evaluating the "Zero Tolerance for Head Contact" Policy Change. Orthop J Sports Med. 2021;9(3):2325967121992375doi: 10.1177/2325967121992375.
Williamson, R. A., Kolstad, A. T., Krolikowski, M., Nadeau, L., Goulet, C., Hagel, B. E., & Emery, C. A. (2021). Incidence of Head Contacts, Penalties, and Player Contact Behaviors in Youth Ice Hockey: Evaluating the "Zero Tolerance for Head Contact" Policy Change. Orthopaedic journal of sports medicine, 9(3), 2325967121992375. https://doi.org/10.1177/2325967121992375
Williamson, Rylen A, et al. "Incidence of Head Contacts, Penalties, and Player Contact Behaviors in Youth Ice Hockey: Evaluating the "Zero Tolerance for Head Contact" Policy Change." Orthopaedic journal of sports medicine vol. 9,3 (2021): 2325967121992375. doi: https://doi.org/10.1177/2325967121992375
Williamson RA, Kolstad AT, Krolikowski M, Nadeau L, Goulet C, Hagel BE, Emery CA. Incidence of Head Contacts, Penalties, and Player Contact Behaviors in Youth Ice Hockey: Evaluating the "Zero Tolerance for Head Contact" Policy Change. Orthop J Sports Med. 2021 Mar 05;9(3):2325967121992375. doi: 10.1177/2325967121992375. eCollection 2021 Mar. PMID: 33748310; PMCID: PMC7940749.
Copy Download .nbib Format: NLM
Sleep and daytime problems during the COVID-19 pandemic and effects of coronavirus infection, confinement and financial suffering: a multinational survey using a harmonised questionnaire.

BMJ open

Partinen M, Holzinger B, Morin CM, Espie C, Chung F, Penzel T, Benedict C, Bolstad CJ, Cedernaes J, Chan RNY, Dauvilliers Y, De Gennaro L, Han F, Inoue Y, Matsui K, Leger D, Cunha AS, Merikanto I, Mota-Rolim S, Nadorff M, Plazzi G, Schneider J, Sieminski M, Wing YK, Bjorvatn B.
PMID: 34903540
BMJ Open. 2021 Dec 13;11(12):e050672. doi: 10.1136/bmjopen-2021-050672.

OBJECTIVES: Sleep is important for human health and well-being. No previous study has assessed whether the COVID-19 pandemic impacts sleep and daytime function across the globe.METHODS: This large-scale international survey used a harmonised questionnaire. Fourteen countries participated during the...

Cite
Partinen M, Holzinger B, Morin CM, et al. Sleep and daytime problems during the COVID-19 pandemic and effects of coronavirus infection, confinement and financial suffering: a multinational survey using a harmonised questionnaire. BMJ Open. 2021;11(12):e050672doi: 10.1136/bmjopen-2021-050672.
Partinen, M., Holzinger, B., Morin, C. M., Espie, C., Chung, F., Penzel, T., Benedict, C., Bolstad, C. J., Cedernaes, J., Chan, R. N. Y., Dauvilliers, Y., De Gennaro, L., Han, F., Inoue, Y., Matsui, K., Leger, D., Cunha, A. S., Merikanto, I., Mota-Rolim, S., Nadorff, M., Plazzi, G., Schneider, J., Sieminski, M., Wing, Y. K., & Bjorvatn, B. (2021). Sleep and daytime problems during the COVID-19 pandemic and effects of coronavirus infection, confinement and financial suffering: a multinational survey using a harmonised questionnaire. BMJ open, 11(12), e050672. https://doi.org/10.1136/bmjopen-2021-050672
Partinen, Markku, et al. "Sleep and daytime problems during the COVID-19 pandemic and effects of coronavirus infection, confinement and financial suffering: a multinational survey using a harmonised questionnaire." BMJ open vol. 11,12 (2021): e050672. doi: https://doi.org/10.1136/bmjopen-2021-050672
Partinen M, Holzinger B, Morin CM, Espie C, Chung F, Penzel T, Benedict C, Bolstad CJ, Cedernaes J, Chan RNY, Dauvilliers Y, De Gennaro L, Han F, Inoue Y, Matsui K, Leger D, Cunha AS, Merikanto I, Mota-Rolim S, Nadorff M, Plazzi G, Schneider J, Sieminski M, Wing YK, Bjorvatn B. Sleep and daytime problems during the COVID-19 pandemic and effects of coronavirus infection, confinement and financial suffering: a multinational survey using a harmonised questionnaire. BMJ Open. 2021 Dec 13;11(12):e050672. doi: 10.1136/bmjopen-2021-050672. PMID: 34903540; PMCID: PMC8671846.
Copy Download .nbib Format: NLM
Drug Levels Associated with Optimal Discrimination Between Remission and Non-Remission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease.

Therapeutic drug monitoring

Dorn-Rasmussen M, Buhl S, Brynskov J, Bay JT, Bolstad N, Klausen TW, Warren DJ, Ainsworth MA, Steenholdt C.
PMID: 34387220
Ther Drug Monit. 2021 Aug 11; doi: 10.1097/FTD.0000000000000913. Epub 2021 Aug 11.

BACKGROUND: In order to implement therapeutic drug monitoring (TDM)-based strategies for infliximab (IFX) in inflammatory bowel disease (IBD), the authors assessed IFX levels for optimal discrimination between remission and non-remission and compared assays for anti-IFX antibodies (Abs).METHODS: The retrospective...

Cite
Dorn-Rasmussen M, Buhl S, Brynskov J, et al. Drug Levels Associated with Optimal Discrimination Between Remission and Non-Remission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease. Ther Drug Monit. 2021;doi: 10.1097/FTD.0000000000000913.
Dorn-Rasmussen, M., Buhl, S., Brynskov, J., Bay, J. T., Bolstad, N., Klausen, T. W., Warren, D. J., Ainsworth, M. A., & Steenholdt, C. (2021). Drug Levels Associated with Optimal Discrimination Between Remission and Non-Remission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease. Therapeutic drug monitoring, . https://doi.org/10.1097/FTD.0000000000000913
Dorn-Rasmussen, Maria, et al. "Drug Levels Associated with Optimal Discrimination Between Remission and Non-Remission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease." Therapeutic drug monitoring vol. (2021). doi: https://doi.org/10.1097/FTD.0000000000000913
Dorn-Rasmussen M, Buhl S, Brynskov J, Bay JT, Bolstad N, Klausen TW, Warren DJ, Ainsworth MA, Steenholdt C. Drug Levels Associated with Optimal Discrimination Between Remission and Non-Remission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease. Ther Drug Monit. 2021 Aug 11; doi: 10.1097/FTD.0000000000000913. Epub 2021 Aug 11. PMID: 34387220.
Copy Download .nbib Format: NLM
Screening for depression in patients in treatment for alcohol use disorder using the Beck Depression Inventory-II and the Hopkins Symptom Checklist-10.

Psychiatry research

Lien IA, Bolstad I, Lien L, Bramness JG.
PMID: 34979381
Psychiatry Res. 2021 Dec 27;308:114363. doi: 10.1016/j.psychres.2021.114363. Epub 2021 Dec 27.

Alcohol use disorder (AUD) and major depressive disorder (MDD) are prevalent disorders that often co-occur. The aim of the study was to investigate how the Beck Depression Inventory (BDI-II) and Hopkins Symptom Checklist (HSCL-10) perform as screening instruments for...

Cite
Lien IA, Bolstad I, Lien L, et al. Screening for depression in patients in treatment for alcohol use disorder using the Beck Depression Inventory-II and the Hopkins Symptom Checklist-10. Psychiatry Res. 2021;308:114363doi: 10.1016/j.psychres.2021.114363.
Lien, I. A., Bolstad, I., Lien, L., & Bramness, J. G. (2021). Screening for depression in patients in treatment for alcohol use disorder using the Beck Depression Inventory-II and the Hopkins Symptom Checklist-10. Psychiatry research, 308114363. https://doi.org/10.1016/j.psychres.2021.114363
Lien, Ingebjørg Aspeland, et al. "Screening for depression in patients in treatment for alcohol use disorder using the Beck Depression Inventory-II and the Hopkins Symptom Checklist-10." Psychiatry research vol. 308 (2021): 114363. doi: https://doi.org/10.1016/j.psychres.2021.114363
Lien IA, Bolstad I, Lien L, Bramness JG. Screening for depression in patients in treatment for alcohol use disorder using the Beck Depression Inventory-II and the Hopkins Symptom Checklist-10. Psychiatry Res. 2021 Dec 27;308:114363. doi: 10.1016/j.psychres.2021.114363. Epub 2021 Dec 27. PMID: 34979381.
Copy Download .nbib Format: NLM
Showing 121 to 125 of 125 entries